Operating characteristics of a Simon two-stage phase II clinical trial design incorporating continuous toxicity monitoring

2012 ◽  
Vol 11 (2) ◽  
pp. 170-176 ◽  
Author(s):  
H.E. Ray ◽  
S.N. Rai
Keyword(s):  
Clinical Trial ◽  
Phase Ii ◽  
Trial Design ◽  
Clinical Trial Design ◽  
Phase Ii Clinical Trial ◽  
Operating Characteristics ◽  
Two Stage ◽  
Toxicity Monitoring

scholarly journals A two‐stage phase II clinical trial design with nested criteria for early stopping and efficacy

2019 ◽  
Vol 18 (6) ◽  
pp. 700-713
Author(s):  
Michelle DeVeaux ◽  
Michael Kane ◽  
Wei Wei ◽  
Daniel Zelterman
Keyword(s):  
Clinical Trial ◽  
Phase Ii ◽  
Trial Design ◽  
Clinical Trial Design ◽  
Phase Ii Clinical Trial ◽  
Early Stopping ◽  
Two Stage

A Bayesian-frequentist two-stage single-arm phase II clinical trial design

2012 ◽  
Vol 31 (19) ◽  
pp. 2055-2067 ◽  
Author(s):  
Gaohong Dong ◽  
Weichung Joe Shih ◽  
Dirk Moore ◽  
Hui Quan ◽  
Stephen Marcella
Keyword(s):  
Clinical Trial ◽  
Phase Ii ◽  
Trial Design ◽  
Clinical Trial Design ◽  
Phase Ii Clinical Trial ◽  
Two Stage

scholarly journals Phase II Clinical Trial Design: Methods in Translational Research from the Genitourinary Committee at the Eastern Cooperative Oncology Group: Table 1.

2006 ◽  
Vol 12 (7) ◽  
pp. 1966-1969 ◽  
Author(s):  
Robert Gray ◽  
Judith Manola ◽  
Scott Saxman ◽  
John Wright ◽  
Jan Dutcher ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Translational Research ◽  
Phase Ii ◽  
Trial Design ◽  
Eastern Cooperative Oncology Group ◽  
Clinical Trial Design ◽  
Design Methods ◽  
Phase Ii Clinical Trial ◽  
Oncology Group

scholarly journals Biomarker-based Bayesian randomized phase II clinical trial design to identify a sensitive patient subpopulation

2014 ◽  
Vol 33 (23) ◽  
pp. 4008-4016 ◽  
Author(s):  
Satoshi Morita ◽  
Hideharu Yamamoto ◽  
Yasuo Sugitani
Keyword(s):  
Clinical Trial ◽  
Phase Ii ◽  
Trial Design ◽  
Clinical Trial Design ◽  
Phase Ii Clinical Trial ◽  
Randomized Phase Ii

Bayesian optimal phase II clinical trial design with time‐to‐event endpoint

2020 ◽  
Vol 19 (6) ◽  
pp. 776-786 ◽  
Author(s):  
Heng Zhou ◽  
Cong Chen ◽  
Linda Sun ◽  
Ying Yuan
Keyword(s):  
Clinical Trial ◽  
Phase Ii ◽  
Trial Design ◽  
Clinical Trial Design ◽  
Phase Ii Clinical Trial ◽  
Time To Event

Novel phase II clinical trial design approaches

2014 ◽  
Vol 19 (S2) ◽  
pp. S16-S18
Author(s):  
N Katz
Keyword(s):  
Clinical Trial ◽  
Phase Ii ◽  
Trial Design ◽  
Clinical Trial Design ◽  
Phase Ii Clinical Trial
Sign in / Sign up

Export Citation Format

Share Document